 Exclusive contents: images and/or videos
An anomalous right coronary artery (RCA) arising from the mid left anterior descending artery (LAD) is extremely rare and
has been described as a variant of single coronary artery anomaly in the past. We report a case of an anomalous, non-
dominant RCA arising from the mid LAD in a patient who was investigated for complaints of chest pain that had both
typical and atypical components to its character. Afterwards a normal stress nuclear perfusion study excluded the
possibility of this anomaly as an aetiology of myocardial ischaemia.
click here to reroll the summary
In a 20-year-old female patient a 64-slice computer tomography was performed because of unexplained ECG changes.
Cine-loops were obtained from a sequence of 10 ECG-gated phases of the cardiac cycle. Both cine-loops and
reconstructed images suggested a coronary cameral fistula between the left coronary artery and the right ventricle via
multiple thin channels. Conventional coronary angiography confirmed this diagnosis. Because of the nature of the shunt,
both percutaneous and surgical closure were excluded. The conclusion being that 64-slice spiral computed tomography
can play a role in functional and anatomical noninvasive imaging of coronary fistulas
click here to reroll the summary
A 68 year-old female underwent PCI to her proximal LAD with implantation of 2 Cypher stents. At the 6-month
angiography the stents were widely patent, with good apposition noted on IVUS. At the 2 year follow-up, the patient
remained well, however there was evidence of marked positive vascular remodelling noted on IVUS. We suggest that late
vascular remodelling with consequent stent malapposition may be an important cause of stent thrombosis and myocardial
infarction after drug-eluting stent implantation.
click here to reroll the summary
Editorial
73
Where the soul lives
EuroInterv.2007;2:408-409
20 years of stenting
76
The balloon-expandable stent
EuroInterv.2007;2:416-421
EAPCI column
Clinical research
78
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial
Chevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D, for the Nobori 1 Clinical Investigators
EuroInterv.2007;2:426-434
80
Endovascular therapy of chronic mesenteric ischaemia
Zeller T, Rastan A, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K, Sixt S, Müller C, Rothenpieler U, Flügel P-C, Neumann F-J
EuroInterv.2007;2:444-451
82
The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatation
Nienaber C, Hamm C, Weber F, Zeymer U, M. Kelm , Levenson B, Bonzel T, Tebbe U, Sabin G, Richardt G, Senges J, the German Cypher Stent Registry for
EuroInterv.2007;2:459-466
84
Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry
Varani E, Saia F, Balducelli M, Guastaroba P, Marrozzini C, Tarantino F, Passerini F, Sangiorgio P, Percoco G, Grilli R, Marzocchi A, Maresta A, for the REAL Investigators
EuroInterv.2007;2:474-480
86
Comparison of the in vitro performance of 6 and 7 French aspiration catheters
Hara H, Nakamura M, Komatsu H, Ikeda N, Shinji H, Makino K, Itaya H, Yamamoto M, Itou N, Tsunoda T, Sugi K
EuroInterv.2007;2:487-492
Special report
Technical report
Expert review
Image in cardiology
Issue 8 has been released thanks to the support of the following partners:
- Cordis, a Johnson & Johnson company
- Boston Scientific
- Medtronic
- Abbott Vascular Devices
- Terumo
- Hexacath
|